Author Correction: PLGA-based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency in Hepatic Carcinoma

Chenlei Cai,Yun Xie,Liangliang Wu,Xiaojing Chen,Hongmei Li,Yan Zhou,Hanbing Zou,Dejun Liu,Yanan Zhao,Xiangdong Kong,Peifeng Liu

DOI: https://doi.org/10.1038/s41598-020-63754-6

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

Plga-Based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency In Hepatic Carcinoma (Vol 7,46250, 2017)

Chenlei Cai,Yuexia Xie,Liangliang Wu,Xiaojing Chen,Hongmei Liu,Yan Zhou,Hanbing Zou,Dejun Liu,Yanan Zhao,Xianming Kong,Peifeng Liu

DOI: https://doi.org/10.1038/s41598-020-63754-6

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Correction: Yan Chen, Et Al. Dual Agent Loaded PLGA Nanoparticles Enhanced Antitumor Activity in a Multidrug-Resistant Breast Tumor Eenograft Model. Int. J. Mol. Sci. 2014, 15, 2761–2772.

Yan Chen,Xue-Lian Zheng,Dai-Long Fang,Yang,Jin-Kun Zhang,Li,Bei Xu,Yi Lei,Ke Ren,Xiang-Rong Song

DOI: https://doi.org/10.3390/ijms17081233

IF: 5.6

2016-01-01

International Journal of Molecular Sciences

Abstract:Theauthorswishtomakeachangetotheirpublishedpaper[1].[...]
PLGA-based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency in Hepatic Carcinoma

Chenlei Cai,Yuexia Xie,liangliang Wu,Xiaojing Chen,Hongmei Liu,Yan Zhou,Hanbing Zou,Dejun Liu,Yanan Zhao,Xianming Kong,Peifeng Liu

DOI: https://doi.org/10.1038/srep46250

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Hepatic carcinoma (HCC) is a lethal disease associated with high morbidity and poor prognosis. Recently years, gene therapies have offered novel modalities to improve the prognosis of HCC patients. MicroRNA-99a (miR-99a) is frequently down-regulated in HCC, where it acts as a tumor suppressor. Therefore, we constructed monomethoxy (polyethylene glycol)-poly(D,L-lactide-co-glycolide)-poly(L-lysine)-lactobionic acid- anti-vascular endothelial growth factor antibody (mPEG-PLGA-PLL-LA/VEGFab or PEAL-LA/VEGFab) nanoparticles (NPs) with highly specific targeting properties as carriers to restore the expression of miR-99a both in vitro and in vivo, to inhibit HCC progression. In vitro, PEAL-LA/VEGFab NPs showed more efficient delivery of miR-99a to HepG2 cells than the conventional transfection reagent LipofectamineTM2000 (Lip2000). The higher delivery efficiency associated with PEAL-LA/VEGFab NPs consequently resulted in down-regulation of target genes and suppression of the proliferation, migration and invasion of HepG2 cells. In vivo, miR-99a-PEAL-LA/VEGFab NPs inhibited tumor xenograft growth in HCC-bearing mice without causing obvious systemic toxicity. Our results demonstrate that PEAL-LA/VEGFab NPs selectively and effectively deliver miR-99a to HCC cells based on the double-targeting character of these nanoparticles, thereby offering potential for translation into effective clinical therapies for HCC.
Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Hui-ha Zhong,Hui-yuan Wang,Jian Gao,Yong-zhuo Huang,Ang Gao,Xian-li Hu,Madiha Saeed,Bin-fan Chen,Ya-ping Li,Hai-jun Yu

DOI: https://doi.org/10.1038/s41401-020-0444-0

IF: 7.169

2020-07-06

Acta Pharmacologica Sinica

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

pharmacology & pharmacy,chemistry, multidisciplinary
Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Xinmin Zhao,Xianghua Wu,Huijie Wang,Songtao Lai,Jialei Wang

DOI: https://doi.org/10.1002/mco2.237

2023-01-01

MedComm

Abstract:[This corrects the article DOI: 10.1002/mco2.237.].
Correction: Liposomes Loading Sodium Chloride As Effective Thermo-Seeds for Microwave Ablation of Hepatocellular Carcinoma

Qunfang Zhou,Songsong Wu,Ningqiang Gong,Xin Li,Jianping Dou,Mengjuan Mu,Xiaoling Yu,Jie Yu,Ping Liang

DOI: https://doi.org/10.1039/c8nr90242a

IF: 6.7

2018-01-01

Nanoscale

Abstract:Correction for ‘Liposomes loading sodium chloride as effective thermo-seeds for microwave ablation of hepatocellular carcinoma’ by Jie Yu, Ping Liang et al., Nanoscale, 2017, 9, 11068–11076.
Author Correction: A Next-Generation Tumor-Targeting IL-2 Preferentially Promotes Tumor-Infiltrating CD8+ T-cell Response and Effective Tumor Control

Zhichen Sun,Zhenhua Ren,Kaiting Yang,Zhida Liu,Shuaishuai Cao,Sisi Deng,Lily Xu,Yong Liang,Jingya Guo,Yingjie Bian,Hairong Xu,Jiyun Shi,Fan Wang,Yang-Xin Fu,Hua Peng

DOI: https://doi.org/10.1038/s41467-020-15532-1

IF: 16.6

2020-01-01

Nature Communications

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Author Correction: Autophagy Inhibition Sensitizes Hepatocellular Carcinoma to the Multikinase Inhibitor Linifanib

Hongming Pan,Zhanggui Wang,Liming Jiang,Xinbing Sui,Liangkun You,Jiawei Shou,Zhao Jing,Jiansheng Xie,Weiting Ge,Xiujun Cai,Wendong Huang,Weidong Han

DOI: https://doi.org/10.1038/s41598-020-74205-7

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Wancun Zhang,Lili Xia,Xiangyu Ren,Mengyuan Cui,Tianguang Liu,Chen Ling,Yanqi Xu,Dawei Deng,Xianwei Zhang,Yueqing Gu,Peng Wang

DOI: https://doi.org/10.1039/d4bm90077d

2024-10-25

Biomaterials Science

Abstract:Correction for 'The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer' by Wancun Zhang et al. , Biomater. Sci. , 2020, 8 , 5941–5954, https://doi.org/10.1039/D0BM01035A.

materials science, biomaterials
Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

Kai Han,Feng-Wei Wang,Chen-Hui Cao,Han Ling,Jie-Wei Chen,Ri-Xin Chen,Zi-Hao Feng,Jie Luo,Xiao-Han Jin,Jin-Ling Duan,Shu-Man Li,Ning-Fang Ma,Jing-Ping Yun,Xin-Yuan Guan,Zhi-Zhong Pan,Ping Lan,Rui-Hua Xu,Dan Xie

DOI: https://doi.org/10.1186/s12943-021-01350-6

IF: 37.3

2021-03-31

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer

Yue Zhou,Qing Zhang,Minjia Wang,Chengzhi Huang,Xueqing Yao

DOI: https://doi.org/10.3389/fonc.2022.916983

IF: 4.7

2022-06-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.827891.].

oncology
Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

Hadi AlShamaileh,Tao Wang,Dongxi Xiang,Wang Yin,Phuong Ha-Lien Tran,Roberto A. Barrero,Pei-Zhuo Zhang,Yong Li,Lingxue Kong,Ke Liu,Shu-Feng Zhou,Yingchun Hou,Sarah Shigdar,Wei Duan

DOI: https://doi.org/10.1038/s41598-020-77490-4

IF: 4.6

2020-12-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Author Correction to ‘bioengineered Mir-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis in Vivo’ [acta Pharmaceutica Sinica B 11 (2021) 3950–3965]

Linglong Deng,Hannah Petrek,Mei-Juan Tu,Neelu Batra,Ai-Xi Yu,Ai-Ming Yu

DOI: https://doi.org/10.1016/j.apsb.2023.07.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.07.027.].
Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles.

Xiaodong Xie,Huifang Nie,Yu Zhou,Shu Lian,Hao Mei,Yusheng Lu,Haiyan Dong,Fengqiao Li,Tao Li,Bifei Li,Jie Wang,Min Lin,Chaihung Wang,Jingwei Shao,Yu Gao,Jianming Chen,Fangwei Xie,Lee Jia

DOI: https://doi.org/10.1038/s41467-019-13863-2

IF: 16.6

2020-01-01

Nature Communications

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction: Powering up the molecular therapy of RNA interference by novel nanoparticles

Wenzhen Liao,Wen Li,Tiantian Zhang,Micheal Kirberger,Jun Liu,Pei Wang,Wei Chen,Yong Wang

DOI: https://doi.org/10.1039/C6BM90031C

2016-01-01

Biomaterials Science

Abstract:Correction for ‘Powering up the molecular therapy of RNA interference by novel nanoparticles’ by Wenzhen Liao et al., Biomater. Sci., 2016, DOI: 10.1039/c6bm00204h.
Correction: Synergic Therapy of Melanoma Using GNRs-MUA-PEI/siIDO2-FA Through Targeted Gene Silencing and Plasmonic Photothermia

Yujuan Zhang,Na Song,Jiamin Fu,Yanling Liu,Xuelin Zhan,Shanshan Peng,Zhi Yang,Xianfang Zhu,Yiguo Chen,Zhigang Wang,Yanrong Yu,Qiaofa Shi,Yingyuan Fu,Keng Yuan,Nanjin Zhou,Thomas E. Ichim,Weiping Min

DOI: https://doi.org/10.1039/c6ra13297a

IF: 4.036

2016-01-01

RSC Advances

Abstract:Correction for ‘Synergic therapy of melanoma using GNRs-MUA-PEI/siIDO2-FA through targeted gene silencing and plasmonic photothermia’ by Yujuan Zhang et al., RSC Adv., 2016, 6, 77577–77589.
Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Siwen Li,Yuxi Liu,Yalan Rui,Liping Tang,Samuel Achilefu,Yueqing Gu

DOI: https://doi.org/10.7150/thno.43075

IF: 11.6

2020-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.24469.].

Author Correction: PLGA-based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency in Hepatic Carcinoma

Plga-Based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency In Hepatic Carcinoma (Vol 7,46250, 2017)

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Correction: Yan Chen, Et Al. Dual Agent Loaded PLGA Nanoparticles Enhanced Antitumor Activity in a Multidrug-Resistant Breast Tumor Eenograft Model. Int. J. Mol. Sci. 2014, 15, 2761–2772.

PLGA-based Dual Targeted Nanoparticles Enhance Mirna Transfection Efficiency in Hepatic Carcinoma

Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Correction: Liposomes Loading Sodium Chloride As Effective Thermo-Seeds for Microwave Ablation of Hepatocellular Carcinoma

Author Correction: A Next-Generation Tumor-Targeting IL-2 Preferentially Promotes Tumor-Infiltrating CD8+ T-cell Response and Effective Tumor Control

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Author Correction: Autophagy Inhibition Sensitizes Hepatocellular Carcinoma to the Multikinase Inhibitor Linifanib

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

Author Correction to ‘bioengineered Mir-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis in Vivo’ [acta Pharmaceutica Sinica B 11 (2021) 3950–3965]

Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles.

Correction: Powering up the molecular therapy of RNA interference by novel nanoparticles

Correction: Synergic Therapy of Melanoma Using GNRs-MUA-PEI/siIDO2-FA Through Targeted Gene Silencing and Plasmonic Photothermia

Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum